A conformational variant of p53 (U-p53AZ) as blood-based biomarker for the prediction of the onset of symptomatic Alzheimer's disease

Authors

S Piccirella, Diadem SpA
L Van Neste, Halixo BV
C Fowler, Diadem SpA
C L Masters, The Florey Institute of Neuroscience and Mental Health
J Fripp, CSIRO
J D Doecke, CSIRO
C Xiong, Washington University School of Medicine in St. Louis
D Uberti, University of Brescia
P Kinnon, Diadem SpA

Journal

The Journal of Prevention of Alzheimer's Disease

Publication Date

1-1-2022

Volume

9

Issue

3

First Page

469

Last Page

479

Document Type

Open Access Publication

DOI

10.14283/jpad.2022.52

Rights and Permissions

Piccirella, S., Van Neste, L., Fowler, C. et al. A Conformational Variant of p53 (U-p53AZ) as Blood-Based Biomarker for the Prediction of the Onset of Symptomatic Alzheimer’s Disease. J Prev Alzheimers Dis 9, 469–479 (2022). https://doi.org/10.14283/jpad.2022.52 This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Recommended Citation

Piccirella, S; Van Neste, L; Fowler, C; Masters, C L; Fripp, J; Doecke, J D; Xiong, C; Uberti, D; and Kinnon, P, "A conformational variant of p53 (U-p53AZ) as blood-based biomarker for the prediction of the onset of symptomatic Alzheimer's disease." The Journal of Prevention of Alzheimer's Disease. 9, 3. 469 - 479. (2022).
https://digitalcommons.wustl.edu/oa_4/455